REGULATORY PHARMA NET MANAGING DIRECTOR, ANITA FALEZZA, INTERVIEWED @ TOPRA ANNUAL SYMPOSIUM 2015 – BERLIN

TOPRA’s Annual Symposia – covering pharmaceuticals, veterinary medicines and medical devices – are together the largest forum for European regulatory…

READ

READABILITY USER TESTING: THE DEADLINE FOR SUBMISSION FOR NATIONALLY AUTHORIZED PRODUCTS IS GETTING CLOSER

For all medicinal products registered in Italy via national procedure, the Marketing Authorization Holder is requested to submit within December…

READ

REGULATORY PHARMA NET EXHIBITS AT THE TOPRA ANNUAL SYMPOSIUM – BERLIN, GERMANY

From 12th till 14th of October RPN exhibits at the TOPRA Annual Symposium which will be held in Berlin at…

READ

EDUCATIONAL MATERIAL IN PILLS

Before the launch, any educational materials provided for in the Risk Management Plan of a centrally approved medicinal product shall…

READ

THE AUTHORISATION OF CLINICAL TRIALS ON MEDICINAL PRODUCTS IN ITALY

The conduct of Clinical Trials on medicinal products in Italy is subject to authorization by the Competent Authority (i.e. Agenzia…

READ

EARLY MARKET ACCESS OPTIONS

The granting of the community marketing authorisation (MA) does not mean a medicinal product is simultaneously available throughout all the…

READ